The Iran war is accelerating plans for Southeast Asia to go nuclear. Experts say it won’t be easy

Key event: On March 23 Vietnam and Russia signed a deal to build a nuclear power plant in Ninh Thuan province, due to come online in about a decade and billed as Southeast Asia’s first modern nuclear plant. Several regional governments (Malaysia, Indonesia, Thailand, the Philippines) are signaling nuclear plans—Indonesia aims for two SMRs by 2034 and Thailand targets 600 MW by 2037—while SMRs are up to ~300 MW per unit and only two experimental SMRs currently operate worldwide. Material risks—public opposition, institutional and regulatory gaps, capital intensity, long build times, and security vulnerabilities—plus historical precedent (the $2.2bn Bataan plant in the Philippines never entered service) mean limited near-term market impact despite heightened energy-security pressures from higher oil and gas prices.

Analysis

Southeast Asia reconsidering nuclear is less about immediate MWh and more about strategic industrial policy: sovereigns will favor vendors who offer bundled financing, long-term fuel supply and regulatory capacity building. That tilts the competitive edge toward large state-backed vendors and firms able to wrap export-credit, construction and operator training into one package — a multi-year revenue stream that bypasses merchant-market price signals. Expect vendor competition to drive M&A and long-term supply contracts (uranium, heavy forgings, instrumentation) rather than discrete turbine-style spot purchases, concentrating value in a smaller set of specialist suppliers.

SMRs change the risk profile but not the institutional requirements — shorter-unit size lowers single-unit capex but raises the number of licensing events, serial manufacturing needs and supply-chain scale-up risk. If SMR commercialization stumbles (delays, cost overruns, failed licensing) the market will bifurcate: specialist suppliers and legacy large-reactor firms diverge in earnings trajectories for 3–7 years. Conversely, credible SMR deployment in even a handful of emerging markets could reprice the long uranium market and create follow-on orders for modular supply chain players.

Near-term catalysts to monitor: export-credit commitments from OECD governments, multi-year uranium contracting by state utilities, and whether cyber/hardening budgets rise alongside project approvals (an underappreciated operating cost). Tail risks that could reverse the trajectory include a major accident or a rapid collapse in gas/oil prices that restores energy security via fuel markets, but those reversals are binary and operate on 1–3 year event windows; institutional capacity failures (regulatory, waste management) are slower, 3–10 year execution risks that will delay or cancel projects and compress supplier multiples.

Key Decisions for Investors

• Long CCJ (Cameco) 12–36 months — buy common or Jan-2028 calls sized 2–4% NAV. Rationale: uranium re-contracting and supply tightening if SMR interest turns into firm orders. Risk: project delays and existing secondary uranium inventories; target 30–60% upside, stop-loss 20%.
• Long BWXT (BWXT) 12–24 months — buy shares or a modest call spread. Rationale: exposure to reactor components, licensing support and recurring service revenue as emerging markets contract for SMR/near‑term builds. Risk: project cadence risk and government procurement cycles; asymmetric 2:1 reward:risk if a pipeline materializes.
• Long NuScale (SMR) equity or speculative long-dated calls (18–36 months) — allocate small, high-risk tranche (≤1% NAV). Rationale: outright beneficiary if SMR orders in emerging markets convert to firm schedules. Risk: high execution and certification risk; expected binary outcome — total loss to 3x+ upside.
• Hedge/adjacent play: buy cybersecurity exposure (CRWD or PANW) 6–18 months — add as insurance against rising defense/cyber budgets tied to critical-infrastructure projects. Rationale: nuclear buildouts raise recurring security spend; target 15–25% upside with defensive beta in sell-offs.